sonomabio.comHealthcareFounded: 2019Funding to Date: $335.1MM
Sonoma Biotherapeutics is a biotech company focused on the development of adoptive Treg cell therapies for autoimmune and inflammatory diseases.
For more details on financing and valuation for Sonoma Biotherapeutics, register or login.
View Enterprise Value for Sonoma Biotherapeutics.
To read this article and more news on Sonoma Biotherapeutics, register or login.